Immunization consensus for children and adolescents with rheumatic diseases;Consenso de imunização para crianças e adolescentes com doenças reumatológicas

Revista Brasileira de Reumatologia

Volumn 49, Issue 5, 2009, Pages 562-589

  Da Silva, Clovis Artur Almeida ^a   Terreri, Maria Teresa R A ^b   Barbosa, Cássia Maria P L ^b   Hilário, Maria Odete E ^b   Pillegi, Gecilmara C S ^a   Ferriani, Virginia P L ^a   Aikawa, Nadia E ^a   Carvalho, Jozélio F ^a   Jesus, Adriana A ^a   Sallum, Adriana M E ^a   Lotito, Ana Paola N ^a   Liphaus, Bernadete L ^a   Magalhães, Claudia S ^c   Len, Cláudio A ^b   Okuda, Eunice M ^d   Campos, Lucia Maria M ^a   Carvalho, Luciana M ^a   Ronchezel, Marcos Vinícius ^d   Dos Santos, Maria Carolina ^d   Romanelli, Paulo Roberto S ^e   Marini, Roberto ^f   Pereira, Rosa Maria R ^a   Sacchetti, Silvana B ^d   Lotufo, Simone ^e   Hirschheimer, Sônia Maria S ^g   Robazzi, Tereza Cristina M V ^h   Vecchi, Ana Paula ⁱ   Moraes, Ana Júlia P ^j   Naka, Erica N ^k   Bica, Blanca ^l   Oliveira, Sheila K F ^l   Bastos, Wanda A ^d   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^e Hospital Municipal Infantil Menino Jesus   (Brazil)

^f UNIVERSITY OF CAMPINAS   (Brazil)

^g Hospital Servidor Público   (Brazil)

^h FEDERAL UNIVERSITY OF BAHIA   (Brazil)

ⁱ Hospital Materno Infantil de Goiás   (Brazil)

^j FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^k FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^l FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

more..

Author keywords

Children; Idiopathic juvenile arthritis; Immunization; Rheumatic disease; Systemic lupus erythematosus; Vaccination

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BCG VACCINE; CHICKENPOX VACCINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ETANERCEPT; GOLD SALT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PREDNISONE; ROTAVIRUS VACCINE; TETANUS TOXOID; TRIPLE VACCINE; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ARTHROPATHY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BRAZIL; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; EVIDENCE BASED PRACTICE; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HEPATITIS A; HEPATITIS B; HUMAN; HYPEREMIA; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INJECTION SITE ABSCESS; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; JAUNDICE; LETHARGY; LICHEN PLANUS; LYMPHADENITIS; MALAISE; MEDICAL RESEARCH; MEDLINE; MENINGOCOCCOSIS; MYASTHENIA GRAVIS; MYELITIS; NEUROLOGIC DISEASE; OSTEOMYELITIS; PAIN; PAPULAR ACRODERMATITIS; PASSIVE IMMUNIZATION; PEMPHIGUS; PNEUMOCOCCAL INFECTION; POLYNEUROPATHY; PUBLICATION; REFERENCE DATABASE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SCIENTIFIC LITERATURE; SEIZURE; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TETANUS; ULCER; UVEITIS; VASCULITIS; VIRUS INFECTION; YELLOW FEVER;

EID: 72849111344     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042009000500007     Document Type: Article

References (87)

1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46:2287-2293
2. Gluck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 2005; 32:1473-1480 (Pubitemid 41113967)
3. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46:1459-1465 (Pubitemid 351589953)
4. Campos-Outcalt D. Immunization update: Latest recommendations from the CDC. J Fam Pract 2007; 56:377-380 (Pubitemid 46801629)
5. Facó MM, Nukumizu LA, Pantoja AJ, Barros PC, Troster EJ, Silva CA. Avaliação dos Óbitos e Necropsias em Pacientes Internados em um Serviço de Reumatologia Pediátrica por um Período de Dez Anos. Rev Bras Reumatol 2005; 45: 55-63.
6. Davies K, Woo P. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) 2002; 41:937-941 (Pubitemid 34905872)
7. Snowden N. Immunisation of immunosuppressed patients with rheumatic diseases. www.arc.org.uk/arthinfo/medpub/6632/6632. asp[cited 2007].
8. Luz KR, Souza DC, Ciconelli RM. Vacinação em pacientes imunossuprimidos e com doenças reumatológicas autoimunes. Rev Bras Reumatol 2007; 47:106-113
9. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmunity Reviews 2008; 8:124-128
10. Atzeni F, Bendtzen K, Bobbio-Pallavicini F et al. Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol 2008; 26:S67-73. (Pubitemid 351578098)
11. th ed. Elk Grove Village, IL; 2005. pp. 672-686
12. Cutolo M, Seriolo B, Pizzorni C et al. Use of glucocorticoids and risk of infections. Autoimmun Rev 2008; 8:153-155
13. Cooke A, Ferraccioli GF, Herrmann M et al. Induction and protection of autoimmune rheumatic diseases. The role of infections. Clin Exp Rheumatol 2008; 26:S1-7.
14. Hepatites virais: o Brasil está atento / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. - Brasília: Ministério da Saúde, 2005.
15. Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol 2007; 13:2238-2239
16. de Carvalho JF, Pereira RM, Shoenfeld Y. Systemic polyarteritis nodosa following hepatitis B vaccination. Eur J Intern Med 2008; 19:575-578 (Pubitemid 351783395)
17. de Carvalho JF, Shoenfeld Y. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. Eur J Intern Med. 2008; 19:383-385 (Pubitemid 351783395)
18. Kuruma KA, Borba EF, Lopes MH, de Carvalho JF, Bonfá E. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 2007; 16:350-354 (Pubitemid 47074837)
19. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38:295-301.
20. Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004; 22:749-755
21. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23:3876-3886 (Pubitemid 40726180)
22. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 2002; 55:982-989
23. Moxey-Mims MM, Preston K, Fivush B, McCurdy F. Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Chesapeake Pediatric Nephrology Study Group. Pediatr Nephrol 1990; 4:171-173 (Pubitemid 20114142)
24. Kasapçopur O, Cullu F, Kamburoǧlu-Goksel A et al. Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63:1128-1130 (Pubitemid 39120366)
25. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32(suppl 1):S16-S24.
26. Block SL, Nolan T, Sattler C et al. Protocol 016 Study Group. Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women. Pediatrics 2006; 118: 2135-2145
27. Garland SM, Hernandez-Avila M, Wheeler CM et al. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases. N Engl J Med 2007; 356:1928-1943.
28. FUTURE II Study Group. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. N Engl J Med 2007; 356:1915-1927 (Pubitemid 46740302)
29. Dhar JP, Essenmacher L, Ager J, Sokol RJ. Ominous cervical cytopathology in women with lupus. Int J Gynaecol Obstet 2005; 89:295-296 (Pubitemid 40779310)
30. Febronio MV, Pereira RM, Bonfa E, Takiuti AD, Pereyra EA, Silva CA. Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus. Lupus 2007; 16:430-435 (Pubitemid 47122217)
31. Centers for disease control and prevention (www.cdc.org).
32. Bekker A, Chou C, Bernstein HH. Update on universal annual influenza immunization recommendations for children. Curr Opin Pediatr 2009; 21:122-126
33. Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenicity issues. Autoimmun Rev 2007; 6:543-546 (Pubitemid 47374614)
34. Abu-Shakra M, Press J, Varsano N, Levy V et al. Specific antibody response after influenza immunization in systemic lupus erythematosus J Rheumatol 2002; 29:2555-2557
35. Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007; 6:300-305
36. Holvast A, Huckriede A, Wilschut J et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65:913-918
37. Brodman R, Gilfillan R, Glass D, Schur PH. Influenza vaccine response in systemic lupus erythematosus. Ann Intern Med 1978; 88:735-740 (Pubitemid 8351371)
38. Louie JS, Nies KM, Shoji KT et al. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 1978; 88:790-792 (Pubitemid 8351381)
39. Malleson PN, Tekano JL, Scheifele DW, Weber JM. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol 1993; 20:1769-1773
40. Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami E. Kyriazopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 2001; 19:589-594 (Pubitemid 32894612)
41. Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 2007; 6:312-314 (Pubitemid 46507995)
42. McCann LJ. Should children under treatment for juvenile idiopathic arthritis receive flu vaccination? Arch Dis Child 2007; 92:366-368
43. Hess EV, Hahn V. Influenza immunization in lupus erythematosus: safe, effective? Ann Intern Med 1978; 88:833-834
44. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 2000; 27:1681-1685 (Pubitemid 30462811)
45. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 2002; 21:369-372
46. Facó MM, Leone C, Campos LM, Febrônio MV, Marques HH, Silva CA. Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus. Braz J Med Biol Res 2007; 40:993-1002. (Pubitemid 47232886)
47. Meisel R, Kuypers L, Dirksen U et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 2007; 109:2322-2326 (Pubitemid 46425870)
48. Lin PL, Michaels MG, Green M et al. Safety and immunogenicity of the American Academy of Pediatrics recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005; 116:160-167
49. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006; 45:106-111
50. Mease PJ, Ritchlin CT, Martin RW et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004; 31:1356-1361 (Pubitemid 38879202)
51. Battafarano DF, Battafarano NJ, Larsen L et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41:1828-1834 (Pubitemid 28465537)
52. Karsh J, Pavlidis N, Schiffman G, Moutsopoulos HM. Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Arthritis Rheum 1980; 23:1294-1298 (Pubitemid 11234047)
53. Klippel JH, Karsh J, Stahl NI, Decker JL, Steinberg AD, Schiffman G. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979; 22:1321-1325 (Pubitemid 10194569)
54. Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 2007; 6:312-314 (Pubitemid 46507995)
55. Ridgway D, Wolff LJ. Active immunization of children with leukemia and other malignancies. Leuk Lymphoma 1993; 9:177-192 (Pubitemid 23136512)
56. Brezinschek HP, Hofstaetter T, Leeb BF, Haindl P, Graninger WB. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol 2008; 20:295-299
57. Centers for Disease Control and Prevention. Preventing Pneumococcal Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49(No RR-9):1-35.
58. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2005; 54(No RR-7).
59. Zonneveld-Huijssoon E, Ronaghy A, van Rossum MA et al. Safety and efficacy of meningococcal C vaccination in juvenile idiopathic arthritis. Arthritis Rheum 2007; 56:639-646 (Pubitemid 46271990)
60. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, editor. 2003 Red Book. Report of the Committee on Infectious Diseases. 26th Ed. Elk Grove Vilage: American Academy of Pediatrics; 2003; pp. 54-81.
61. Hib: Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância e Epidemiologia, Programa Nacional de Imunizações. Manual dos Centros de Referência para Imunobiológicos Especiais (CRIES). 2006.
62. Mota LM, Oliveira AC, Lima RA, Santos-Neto LL, Tauil PL. Vaccination against yellow fever among patients on imunossupressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 2009; 42:23-27
63. Global Advisory Committee on vaccine safety Dec 2007. Wkly Epidemiol Rec 2008; 83:287-292
64. Joint WHO-CDC Conference on laboratory quality systems, Lyon, April 2008- joint statement and recommendations. Wkly Epidemiol Rec 2008; 83:285-292
65. Brasil. Ministério da Saúde. Fundação Nacional de Saúde. Manual de Normas de Vacinação. 3. ed. Brasília: Ministério da Saúde, 2001.
66. Colditz GA, Berkey CS, Mosteller F et al. The efficacy of Calmette- Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 1995; 96:29-35.
67. Wunsh Filho V, de Castilho EA, Rodrigues LC, Huttly SR. Effectiveness of BCG vaccination against tuberculous meningitis: a case-control study in São Paulo, Brazil. Bull Word Health Organ 1990; 68:69-74.
68. Camargos PAM, Guimarães MDC, Antunes CMF. Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case control study. Int J Epidemiol 1988; 17:193-197
69. Barreto MB, Cunha SS, Pereira SM et al. BCG neonatal protects children and young adults against all forms tuberculosis in Brazil. Int J Tuberc Lung Dis. 2005; 10:1171-1173
70. Brasil. Ministério da Saúde. Vigilância em Saúde Caderno de Atenção Básica 2007.
71. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI. Update on Rotavirus Vaccines. Pediatr Infect Dis J 2005; 24:947-952
72. Cortese MM, Parashar UD. Prevention of Rotavirus Gastroenteritis Among Infants and Children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) - CDC 2009; 58:1-25.
73. www.saude.sp.gov.br/htm/hidriva/rotavirus-dados.html
74. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde, Departamento de Vigilância e Epidemiologia, Programa Nacional de Imunizações. Manual dos Centros de Referência para Imunobiológicos Especiais (Cries). 2006. Disponível em URL: http://www.cve.saude.sp.gov.br/ (acesso em 20/03/09)
75. Global Advisory Committee on Vaccine Safety, 12-13 December 2007. Wkly Epim Rec 2008; 83:37-44.
76. Pileggi GC, Souza CBS, Ferriani, VPL. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases using methotrexate and glucocorticoids. Arthritis Care Res, no prelo.
77. Feijó RB, Cunha J, Krebs LS. Vaccination schedule for childhood and adolescence: comparing recommendations. J Pediatr (Rio J) 2006; 82:S4-14. (Pubitemid 44661476)
78. O' Neill SG, Isenberg DA. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 2006; 15:778-783
79. Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 2007; 66:1384-1387 (Pubitemid 47492487)
80. Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology 2009; 48:144-148
81. Centers for Disease Control and Prevention (CDC). Pertussis. United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73-76
82. de Carvalho AP, Pereira EM. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J) 2006; 82:S15-24.
83. Brasil, Ministério da Saúde. Calendário básico de vacinação. PORTARIA n° 97/GM de 8 de abril de 2004. Disponível em: http:// portal.saude.gov.br/portal/saude/visualiza- texto.cfm?idtxt=21462
84. World Health Organization. Pertussis vaccines - WHO position paper. Wkly Epidemiol Rec 2005; 80:31-39
85. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2002; 51:1-35.
86. Perkkali T, Stenvik M, Ruutu T, Hovi T, Volin L, Ruutu P. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20:663-668 (Pubitemid 27477580)
87. Stenvik M, Hovi L, Siimes MA, Roivainen M, Hovi T. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovirus campaign. Pediatr Infect Dis J 1987; 6:1106-1110 (Pubitemid 18029588)